Skip to main content

For informational and research purposes only.

Medical DisclaimerTerms of Use

Compounded Testosterone Cream: The Definitive Guide

Labeled doses, scrotal and torso use, how accurate compounded creams are, transfer to partners and children, blood-test timing and what men report.

Compounded testosterone cream at a glance.

Compounded testosterone cream at a glance. Plain testosterone, with no ester, mixed into a cream base by a pharmacy for one prescription and absorbed through the skin. No testosterone cream is approved in the US, UK or Canada; the only approved testosterone cream found is AndroForte 5 in Australia (5%, 50 mg per mL). Strength of a compounded cream is set by each prescription. Applied to the skin of the scrotum or the torso. Formula C19H28O2, 288.4 g/mol. The drawing shows the testosterone four-ring skeleton with its 17-beta hydroxyl group and no ester, next to a generic unlabeled cream pump. Simplified drawing, not a 3D structure. How it works: testosterone passes through the skin into small blood vessels over the day; scrotal skin absorbs far more, so the labeled start is 25 mg there and 100 mg on the torso; in the label studies, scrotal doses peaked 3.3 to 5.3 hours after application on average and 25 mg kept levels in the normal range for more than 16 hours, while torso cream peaked about 14.8 hours after application; the pituitary lowers LH, so the testicles make less testosterone and sperm. Used for testosterone replacement in men with confirmed hypogonadism; the American Urological Association prefers commercially made products when possible. Typical labeled dose, AndroForte 5 in Australia: 25 mg a day on the scrotum or 100 mg a day on the torso; no dose is established for compounded cream. How often: once daily, preferably in the morning, with blood tests after day 15. Status: compounded cream is not FDA-approved; testosterone is US Schedule III, UK Class C, Canada Schedule IV and Australia Schedule 4, and prohibited in sport at all times under the WADA list. Checked September 2026.

Compounded testosterone cream

Plain testosterone (no ester) mixed into a cream by a pharmacy for one prescription, absorbed through the skin

Compounded to prescription (US and elsewhere) · the only approved testosterone cream found is AndroForte 5 (Australia)

Testosterone, no ester Strength set per prescription (AndroForte 5: 50 mg/mL) On the skin: scrotum or torso C19H28O2, 288.4 g/mol

O OH Testosterone no ester attached In a cream pump or tube O OH Testosterone no ester attached In a cream
  • Testosteronethe hormone itself, with no ester
  • Creamcarries it into the skin; strength varies by pharmacy

Simplified drawing, not a 3D structure. The pump is generic, not a product image.

How it works

Human pharmacology and label data

0 h6 h12 h18 h24 hScrotumpeak 3.3–5.3 hTorsopeak about 14.8 h

Average time to peak after one application of AndroForte 5 (label studies). Individual absorption varies.

  1. Through the skin

    Testosterone passes through the skin into small blood vessels over the day.

  2. Site sets the dose

    Scrotal skin absorbs far more: the labeled start is 25 mg there, 100 mg on the torso.

  3. Daily rise and fall

    Scrotal doses peak within hours and stay in the normal range for over 16 hours at 25 mg.

  4. Own signal off

    The pituitary lowers LH, so the testicles make less testosterone and sperm.

Used for

Testosterone replacement in men with confirmed hypogonadism

The AUA prefers commercially made products when possible

Typical labeled dose

25 mg a dayon the scrotum, or 100 mg a day on the torso (AndroForte 5, Australia)

No dose is established for compounded cream

How often

Once dailypreferably in the morning

Blood tests after day 15

Status

  • Compounded cream: not FDA-approved
  • Controlled: US Schedule III, UK Class C, Canada Schedule IV
  • Australia: Schedule 4 (AndroForte 5 approved)
  • Sport: prohibited at all times (WADA S1)

Checked Sep 2026

Conceptual summary: the molecule and cream dispenser are simplified drawings, not a product image. Doses come from the only approved testosterone cream label found (AndroForte 5, Australia); the absorption points come from its label studies; status and sport rules come from regulators (checked September 2026).
Published by DoserlyUpdated Next scheduled review: December 202645 min readHow this guide was made
In this guide

What is compounded testosterone cream?

Compounded testosterone cream is testosterone powder mixed into a cream base by a pharmacy for one person's prescription. It is rubbed into the skin once or twice a day, and the testosterone is transdermal (absorbed through the skin) into the blood. In the United States no testosterone cream is FDA-approved, so every testosterone cream there is compounded. [1], [2]

Compounding means a pharmacist makes a medicine to order instead of dispensing one from a factory. FDA's own summary is blunt: compounded drugs are not FDA-approved, which means FDA does not verify their safety, effectiveness or quality before they are marketed, and they should only be used when an approved drug cannot meet a patient's needs. [1]

The testosterone in a cream is plain testosterone, the same molecule the testicles make, with no chemical tail (no ester) attached. It is often described as "bioidentical". That word describes the molecule, not the product. The US National Academies of Sciences, Engineering, and Medicine (NASEM) found too little evidence to support compounded hormone therapy for low testosterone in men. The Endocrine Society sees "no rationale" for routinely prescribing custom compounded hormones. [3], [20], [21]

The only testosterone cream approved as a medicine that this guide found is AndroForte 5 in Australia, labeled for men whose low testosterone has been confirmed by symptoms and blood tests. It anchors the doses in this guide because it is the only cream with an official label, dose rules and published study data. [3], [22]

ProductWhereStrengthWhere it is appliedStatus (checked September 2026)
Compounded testosterone creamUnited States (also sold in Canada and elsewhere)Set by each prescription, often written as a percentage; 20% is 200 mg/mLSet by the prescriberNot FDA-approved; made under pharmacy compounding rules
AndroForte 5Australia5% (50 mg/mL), 50 mL tube with a 0.25 mL graduated applicatorWhole scrotum or torsoApproved prescription medicine (Schedule 4)
AndroForte 2Imported into Japan2% (20 mg/mL)Scrotum in the study that used itImported; not locally approved
Unlicensed "specials"United KingdomVariesVariesUnlicensed; ordered for an individual patient

[1], [3], [23], [24], [25]

Testosterone cream is a controlled substance: Schedule III in the United States. It is also different from the approved testosterone gels (such as AndroGel), which have fixed strengths, US FDA labels and a boxed warning about transfer; see the testosterone gel guide. [14], [26]

Conceptual cross-section of skin with a thin film of cream on the surface and testosterone passing through the outer skin layer into small blood vessels. It shows anatomy, not a measured drug effect.
Testosterone in a cream passes through the outer layer of skin and then into small blood vessels. Thin skin, such as scrotal skin, lets far more through. This generated illustration explains anatomy; it is not clinical evidence.

Typical Compounded Testosterone Cream Protocols

Transdermal (absorbed through the skin) · the only labeled cream is AndroForte 5, 50 mg/mL; compounded creams have no fixed strength · amounts are per daily application, with the weekly total shown separately · applied amounts are not absorbed amounts and cannot be compared with injected doses · each row is one source's complete schedule [3], [4], [1]
SourceAmount each timeHow oftenWeekly totalAdjusted bySource type
Australian label · AndroForte 5 on the whole scrotum25 mg (0.5 mL) to start; changed in 12.5 mg (0.25 mL) steps; at most 50 mg (1 mL) a dayOnce daily, about the same time, preferably morning175 mg at the starting dose (up to 350 mg)Blood testosterone 3 hours (peak) and 24 hours (trough) after an application, after day 15, plus symptomsLabel
Australian label · AndroForte 5 on the torso100 mg (2 mL) to start; changed in 50 mg (1 mL) steps; at most 200 mg (4 mL) a dayOnce daily, about the same time, preferably morning700 mg at the starting dose (up to 1,400 mg)Morning blood testosterone before the day's application, after day 15, plus symptomsLabel
The torso means the abdomen and the sides of the body from the waist to just below the armpits
Guidelines · AUA, Endocrine Society, European Association of Urology (EAU), British Society for Sexual Medicine (BSSM), Canadian Urological Association (CUA), Society for Endocrinology, US Veterans Affairs (VA)Not establishedNot establishedNot establishedThe AUA advises extra monitoring and dose changes when compounded testosterone is usedGuideline
No guideline gives a cream dose; the AUA recommends commercially made testosterone over compounded testosterone when possible
US compounded cream · clinic practiceNot establishedNot establishedNot establishedNo published protocol foundNo verifiable clinic protocol source
Strengths and amounts that men report are described in the community section, not here

The only labeled cream starts at 25 mg a day on the scrotum or 100 mg a day on the torso, once each morning; the scrotal dose is a quarter of the torso dose because scrotal skin absorbs far more. No guideline and no published clinic protocol gives a dose for compounded cream, so a compounded prescription rests on the prescriber's judgment and follow-up blood tests. [3], [6], [4]

Titration Adjusting the dose in steps
The AndroForte 5 label waits until after day 15, then checks blood testosterone: scrotal users at 3 hours (the peak) and 24 hours (the trough) after an application, torso users in the morning before applying. The dose moves by 0.25 mL on the scrotum or 1 mL on the torso, and the label recommends rechecking when switching between the scrotum and the torso or from another testosterone product. Guidelines give timing only for gels, not creams (see blood-test timing). The AUA adds that compounded testosterone may need more monitoring and dose changes than commercial products. [3], [4]
Breaks and cycles
Not applicable. Testosterone replacement is continuous treatment; no label or guideline describes planned breaks or cycles for cream. Stopping is a separate decision (what happens when you stop). [3], [27]

Read the units. A cream's strength is usually written as a percentage or as milligrams per millilitre (mg/mL): 5% is 50 mg/mL, 10% is 100 mg/mL and 20% is 200 mg/mL. The amount you apply is the strength times the volume. On AndroForte 5, 0.5 mL × 50 mg/mL = 25 mg. On a compounded 20% cream, 0.25 mL is 50 mg, twice AndroForte's scrotal starting dose in half the volume. Some compounded labels give strength per gram (mg/g) instead, and pump dispensers ("clicks") deliver different volumes: in one published case, one pump was about 0.5 mL, while men online describe 2 clicks as 0.5 mL in total. Ask the pharmacist what one pump delivers in mg. [3], [28], [29] The TRT dose calculator shows the same mg-to-mL arithmetic for injection vials.

Applied is not absorbed. A 100 mg daily cream is not comparable with a 100 mg injection. For AndroGel 1%, a gel, about 10% of the applied testosterone reaches the blood; no label gives an equivalent figure for any cream. That is why weekly totals for cream look far larger than injection doses: the two numbers measure different things. [30], [3]

These are labeled doses; prescribers adjust them using blood tests and symptoms. The ranges above are for adult men. For women, see testosterone therapy for women, which uses different products and far smaller doses.

Cautions for every schedule above. The label rules out testosterone in known or suspected breast or prostate cancer and in anyone allergic to the cream's ingredients (AndroForte contains almond oil). Cream on the skin can pass to partners and children (transfer). Testosterone can suppress sperm production (fertility). Hematocrit, blood pressure and PSA (prostate-specific antigen, a prostate blood test) need checking (monitoring). [3], [11]

Where schedules differ: compounded vs approved, scrotum vs torso, once vs twice a day, cream vs gel and blood-test timing ↓

Where these numbers come from

The two label rows come from the Australian product information for AndroForte 5 (testosterone 5% w/v cream), revised August 10, 2023, sections 4.2 and 4.4. Weekly totals are simple multiples of the daily dose. The label does not state them. [3]

The guideline row reflects a search of the AUA (2018, validity reconfirmed 2024), Endocrine Society (2018), EAU (2026), BSSM (2023), CUA (2021), Society for Endocrinology (2022) and VA (January 2026) documents. None gives a dose for testosterone cream. The BSSM lists "5% testosterone cream, small volume applied to scrotum" as licensed in Australia and for import into the UK, without a dose. [4], [31], [32], [25], [33], [27], [34]

The US clinic row is "not established" because no peer-reviewed practice paper or published clinic protocol with a complete compounded-cream schedule for men was found in PubMed, Europe PMC or the regulatory record. An earlier version of this guide gave "200 mg/mL, 1–2 pumps (50–100 mg) to the scrotum"; that figure had no identifiable source, and 100 mg is twice the only label's scrotal maximum, so it was removed. Trial doses are listed separately below.

Open the searchable source directory

What doses did cream studies use?

Transdermal · amounts are per daily application · each row is one study's complete schedule; none outranks the label rows above, and none tested a US compounded cream [35], [36], [23], [37]
SourceAmount each timeHow oftenWeekly totalAdjusted bySource type
Indonesian crossover trial (2015) · AndroForte 5% on the scrotum50 mgOnce daily for 24 weeks350 mgFixed doseHuman trial
44 men aged about 61 with memory complaints, not selected for low testosterone
Japanese crossover trial (2023) · AndroForte 2 (2%) on the scrotum10 mg (0.5 mL)Once daily, morning, for 4 weeks70 mgFixed doseHuman trial
23 men aged 42–71 with late-onset hypogonadism; a 2% cream, not the 5% product
Australian bioequivalence study (2016) · AndroForte 5 on the torso100 mg (2 mL)Once daily for 30 days700 mgFixed doseHuman trial
Compared with 50 mg a day of 1% gel; same as the label's torso starting dose

The rows are alternatives, not steps to move through. The two scrotal studies used 10 mg and 50 mg a day, the lowest and highest ends of anything published for cream; both fall at or under the label's scrotal maximum of 50 mg a day. [35], [23], [3]

What is compounded testosterone cream commonly used for?

Its purpose is the same as every form of testosterone replacement therapy (TRT): replacing testosterone in men whose bodies cannot make enough because of a medical cause, confirmed by symptoms and repeated morning blood tests. The AndroForte 5 label is written for exactly that group. [3], [31]

Why a cream rather than an approved product? The reasons prescribers and patients give fall into a few groups, and the evidence behind each differs:

  • No needles, and a daily routine. Many men who fear needles or react to injection oils ask about cream; that is a frequent topic in public forums (community). [38], [39]
  • Scrotal application. US gel labels forbid applying gel to the genitals, while the AndroForte label allows the scrotum, where a small dose goes a long way. In the US, a scrotal product is therefore compounded by definition. [26], [30], [3]
  • Flexible strengths and allergy. Compounding can make strengths or bases that approved products do not offer, and can leave out an ingredient a person is allergic to. NASEM says compounded hormones should be limited to a documented allergy or a needed dosage form that no approved product provides, and that "patient preference alone should not determine" their use. [20], [40]
  • Cost. The AUA notes that compounded gels and creams "are routinely less expensive than branded forms". Prices vary widely; see cost. [4]

What does testosterone replacement improve?

In trials of men with low testosterone, testosterone mainly improves sexual desire and activity. In the Testosterone Trials, which gave a gel to men 65 and older, it also improved erectile function and lifted mood a little. It did not improve energy, and walking did not improve in the physical function trial itself. Those large trials did not test cream. [41]

Cream-specific outcome data are thin. In a 4-week Japanese trial, a 2% scrotal cream raised testosterone but did not improve an aging-symptom questionnaire, while a new 2% gel at the same 10 mg dose did. In a 24-week Indonesian trial in older men with memory complaints, 50 mg of scrotal cream raised testosterone, free testosterone and DHT and lowered the pituitary signal luteinizing hormone (LH); it was not designed to test low-testosterone symptoms. [23], [35]

How long does testosterone cream take to work?

Blood levels rise fast: the AndroForte label reports testosterone rising from the first hour after an application and reaching the normal range within 24 hours. Symptoms change more slowly, and no study has timed them on cream. For any form, the Canadian Urological Association tells men to expect changes in sex drive, energy and sexual function after 3 months or longer. Changes in body composition and bone take 6 months or more. [3], [33] See the results timeline guide.

Where do compounded testosterone cream protocols differ?

There is only one cream label, and it is Australian. Everything else about cream, from strength to site to how often to apply it, is decided prescription by prescription, so the real disagreements are about whether to compound at all, where to apply, how often, and when to test.

Compounded or approved: what do guidelines say?

Guidelines lean firmly toward approved products. The AUA recommends that "commercially manufactured testosterone products should be prescribed rather than compounded testosterone, when possible" (a conditional recommendation). Its reason is that compounded testosterone shows "considerable variation in potency and quality, even between samples from the same pharmacy". The Canadian Urological Association warns of "significant variability of testosterone concentrations" in compounded products, and the Endocrine Society's 2016 statement finds "no rationale for routine prescribing" of custom compounded hormones. [4], [33], [21]

The counterpoint is practical. The AUA itself notes that compounded gels and creams are usually cheaper than branded products. NASEM accepts a documented allergy or a needed dosage form as valid reasons. And in the US, anyone who wants a cream, or wants to apply testosterone to the scrotum, has no approved option. [4], [20], [26]

The accuracy data behind the guidelines' caution are in Does compounded cream contain what the label says?

Scrotum or torso?

Where the cream goes changes the dose more than anything else. Scrotal skin is thin and lets steroids through easily. The AndroForte label starts at 25 mg on the scrotum and 100 mg on the torso, and Australia's Pharmaceutical Benefits Scheme (PBS) criteria add that the cream "must be applied to the scrotum, where possible". [6], [3], [42]

The trade-off is DHT. A 24-week trial in 162 men tested a 2.5% gel that was washed off 10 minutes after each application. 25 mg a day on scrotal skin gave levels equivalent to testosterone patches, while 125 mg on other skin gave higher levels. Prostate size, PSA and prostate symptoms did not differ between the groups. Scrotal application raises DHT more (why). [43]

Other sites (shoulders, arms, inner thighs) are common on compounded prescriptions, but only the scrotum and torso have label dosing. Men online describe large differences between sites on the same cream, such as one man's result above 1,500 on the scrotum and 310 with the same amount on the shoulders (units not stated). [3], [44]

Once or twice a day?

The label says once daily, preferably in the morning. Twice-daily schedules are common on compounded prescriptions and in forum accounts, usually to avoid an afternoon "crash", but no label, guideline or published protocol gives a twice-daily cream schedule. Scrotal single doses kept testosterone in the normal range for at least 12 hours (12.5 mg) and more than 16 hours (25 and 50 mg). [3], [45], [46]

When a prescriber splits a dose, the daily total is still the number that matters: 50 mg twice a day is 100 mg a day, twice the label's scrotal maximum.

Is cream the same as gel?

Not milligram for milligram. A 30-day crossover study enrolled 16 men, and 14 were in the final analysis. In it, 100 mg a day of AndroForte 5 on the torso gave the same blood levels as 50 mg a day of a 1% gel, so the cream needed twice the applied amount. In the Japanese trial, 10 mg on the scrotum raised total testosterone to 9.86 ng/mL with the 2% gel but 7.30 ng/mL with the 2% cream. Bases, strengths and absorption differ, so switching between a cream and a gel needs new blood tests. [37], [3], [23]

When should blood be drawn on cream?

On cream, the time since the last application changes the result a lot, and only the AndroForte label gives cream-specific timing. Guidelines give timing for gels, which behave similarly but not identically.

SourceWhen to drawNotes
AndroForte 5 label, scrotum3 hours (peak) and 24 hours (trough) after an application, after day 15Two draws
AndroForte 5 label, torsoMorning, before the day's application, after day 15Aims for a trough in the normal range
AUA 2018 (gels)2–4 weeks after starting, with the gel applied that dayTarget 450–600 ng/dL (about 16–21 nmol/L)
Endocrine Society 2018 (gels)2–8 hours after application, after at least 1 weekTarget the middle of the normal range
BSSM 2023 (gels)2–4 hours after applicationTarget 15–30 nmol/L
Society for Endocrinology 2022 (gels)2–6 hours after applicationTarget the middle of the normal range

[3], [4], [31], [25], [27]

Scrotal cream peaks within a few hours. The label reports an average time to peak of 3.3–5.3 hours for the study it describes, while that study's own abstract reports 1.9–2.8 hours. Torso cream peaked much later, around 14.8 hours. A single case report of scrotal compounded cream measured 1,204.7 ng/dL within 2 hours, far above guideline targets. [3], [6], [47]

That spread explains most confusing results. A draw 3 hours after scrotal cream measures the peak; a draw 24 hours later measures the trough; a result without its timing is hard to interpret. Write down when you applied the cream, where, and how much, next to every result. See TRT blood work.

What happens when you stop compounded testosterone cream?

The cream leaves the body within days; your own hormone production takes much longer to return.

  • The last application. No study has measured how fast levels fall after stopping a cream. For comparison, the AndroGel 1.62% label says levels return to about their starting point within 48–72 hours of the last dose, and the AndroGel 1% label says by the fifth day. [26], [30]
  • Your own testosterone. Testosterone on the skin switches off the pituitary's signals to the testicles, just as injections do: in the 24-week cream trial, LH fell. How fast LH and follicle-stimulating hormone (FSH) recover depends on the original cause of low testosterone and how long treatment lasted; in men with a lasting cause, low testosterone is expected to return. [35], [3], [27]
  • Sperm. No cream-specific recovery data exist. In contraceptive trials of 1,549 healthy men given hormones, sperm counts returned to 20 million per mL in 67% within 6 months, 90% within 12 months and 100% within 24 months. [48]
  • Children and partners. Stopping also ends transfer risk: in one published case, a young boy's testosterone fell from 1,460 ng/dL to 20 ng/dL within 2 months of his father stopping a compounded cream. [7]

See stopping TRT for the full picture.

How does compounded testosterone cream compare with other forms?

It is a daily topical, like the approved gels, but with no fixed strength or label outside Australia. Compared with injections, levels rise and fall within each day instead of peaking after each shot. Whether skin products raise red blood cells less is not settled: in trials, gel raised hematocrit about 3.0 points and injections about 4.0, a difference that was not statistically significant. Compared with approved gels, a compounded cream trades a checked product for flexibility. [3], [10], [4]

How is testosterone absorbed through the skin?

The outer layer of skin soaks up testosterone and releases it into the blood over the day, so the skin, not the liver or a depot, sets the pace. The AndroForte label says the testosterone half-life is "controlled by skin permeation", that the skin route avoids the liver's first pass, and that daily swings are similar in size to the body's own daily rhythm. Testosterone itself lasts only 10 to 100 minutes once it is in the blood. [3], [30]

How much gets through depends on the skin. Thin scrotal skin absorbs much more than the torso or arms, and the Iyer study noted scrotal skin's "high steroid permeability". No primary source gives the percentage of a cream dose absorbed at any site. [6], [3]

What do blood levels look like across a day?

Two panels. Left: measured peak testosterone after one scrotal dose of AndroForte 5 in 11 healthy men whose own testosterone was switched off: 12.5 mg, 19.8 plus or minus 3.8 nmol/L; 25 mg, 21.9 plus or minus 2.8; 50 mg, 28.8 plus or minus 3.8 (mean plus or minus SEM), against a study normal range of 6.2 to 26.9 nmol/L. Levels stayed in range for at least 12 hours after 12.5 mg and more than 16 hours after 25 or 50 mg; DHT peaked at 4.5 to 4.9 nmol/L at every dose. Right: timing over 24 hours after one application. Scrotum: average peak 3.3 to 5.3 hours, with the label's peak draw at 3 hours and trough draw at 24 hours. Torso: average peak about 14.8 hours, with a morning draw before the next application; average rise about 7.7 nmol/L, and a day-30 average of 11.4 nmol/L versus 11.3 on a 1% gel. Blood tests on the label come after day 15.

Scrotum or torso: how high, how fast, when to test

Measured peak after one scrotal dose

11 healthy men with their own testosterone switched off, AndroForte 5 (5%). Shaded band: the study normal range, 6.2–26.9 nmol/L (180–780 ng/dL).

12.5 mg (0.25 mL)
Peak 19.8 ± 3.8 nmol/L (about 570 ng/dL). In the normal range for at least 12 hours.
25 mg (0.5 mL)
Peak 21.9 ± 2.8 nmol/L (about 630 ng/dL). In the normal range for more than 16 hours.
50 mg (1 mL)
Peak 28.8 ± 3.8 nmol/L (about 830 ng/dL). In the normal range for more than 16 hours.
DHT
Peaked at 4.5–4.9 nmol/L at every dose, above the normal range of 0.24–2.21 nmol/L.

When it peaks, and when to test

Scrotum (25 mg start)
Average peak 3.3–5.3 hours after applying. The label checks blood at 3 hours (peak) and 24 hours (trough), after day 15.
Torso (100 mg start)
Average rise about 7.7 nmol/L, peaking about 14.8 hours after applying. The label checks blood in the morning before the next application, after day 15. Day 30 average level 11.4 ± 5.2 nmol/L (about 330 ng/dL), vs 11.3 ± 3.7 on 50 mg of a 1% gel.

Scrotal cream peaks within hours and torso cream much later, so a cream result means little without the time since the last application.

Measured testosterone after single scrotal doses of AndroForte 5 (12.5, 25 and 50 mg) and after the 100 mg torso dose, with the label's two scrotal draw times marked. Points are label and study values; the connecting lines are for reading only, not a prediction for any person. Sources: AndroForte 5 Australian product information · Iyer 2017 (scrotal pharmacokinetics).

In 11 healthy men whose own testosterone had been switched off with another hormone, single scrotal doses of 12.5, 25 and 50 mg produced average peaks of 19.8, 21.9 and 28.8 nmol/L (about 570, 630 and 830 ng/dL). Levels stayed in the normal range for at least 12 hours after 12.5 mg and more than 16 hours after 25 or 50 mg. On the torso, 100 mg raised testosterone by about 7.7 nmol/L on average, peaking around 14.8 hours after application; after 30 days, the average level over the day was 11.4 nmol/L (about 330 ng/dL). [3], [6]

Individual results vary far more than averages suggest. The label says absorption is "variable between individuals", and forum accounts on similar daily amounts range from below pretreatment levels to above 2,000 ng/dL (community). [3]

Why does scrotal application raise DHT?

Scrotal skin is thought to turn more testosterone into dihydrotestosterone (DHT), a stronger androgen, through an enzyme called 5-alpha reductase. After single scrotal doses, DHT peaked at 4.5–4.9 nmol/L on average, above the label's normal range of 0.24–2.21 nmol/L, whatever the dose. [3], [6], [49]

The pattern is old and consistent. With scrotal testosterone patches in the 1980s and 1990s, the DHT-to-testosterone ratio tripled (from 0.2 to 0.6). DHT stayed about three times higher over 7 to 10 years (1.3 to 3.9 nmol/L), with normal hemoglobin and low PSA throughout. In a small study of a compounded gel, DHT rose nearly tenfold (20.5 to 199.2 ng/dL) in 6 weeks. [49], [50], [51]

What it means is less clear. The AndroForte label says there is "no evidence to suggest that high circulating DHT concentrations have a deleterious effect on the prostate and cardiovascular safety profile", and the 24-week scrotal gel trial found no prostate differences. No study has measured hair loss on scrotal testosterone. [3], [43]

What is in the cream?

AndroForte 5 is an oil-in-water cream containing almond oil and preservatives called hydroxybenzoates (parabens), which matter for anyone with a nut or paraben allergy. Compounded bases vary by pharmacy, and US compounders are not required to supply a full product label or package insert. Men online describe itching that changed when the pharmacy switched bases. [3], [20], [52]

How should testosterone cream be stored?

Follow the label or the pharmacy's instructions; the two differ because only the approved cream has a studied in-use period.

ProductStorageAfter opening
AndroForte 5 (Australia)Below 25 °C; do not freeze; keep the tube closed until useUse within 125 days of opening
Compounded creamAs printed by the pharmacyThe pharmacy sets a "beyond-use date"

[3]

A beyond-use date is the pharmacy's own expiry date for a compounded product. How long a cream stays at strength depends on its base and container. One laboratory study found testosterone at 0.1% and 20% stayed stable for 180 days in one commercial cream base and pump container. That result says nothing about other bases. [53]

Showering and swimming. No study has tested washing after cream. Gel labels say to wait at least 2 hours (AndroGel 1.62%) or 5 hours (AndroGel 1%). In a gel study, washing 2 or 6 hours after application lowered the day's exposure by 10–14%, and washing at 10 hours made no difference. [26], [30], [54]

For carrying cream on a trip, see traveling with testosterone.

What does compounded testosterone cream do to fertility, estrogen and red blood cells?

These three effects come with every form of testosterone; each has its own hub guide. Here is what is specific to cream.

Fertility. Testosterone through the skin suppresses sperm production like other forms: in two trials, AndroGel 1.62% markedly reduced sperm production, while enclomiphene did not. The AndroForte label warns of suppressed sperm production. Guidelines advise against testosterone for men trying to conceive. See TRT and fertility. [11], [3], [4]

Estrogen. Some testosterone becomes estradiol. After single scrotal doses and over 24 weeks of scrotal cream, estradiol did not change significantly; in 11 men on scrotal patches for 7 to 10 years it rose from 52.3 to 71.3 pmol/L. No study shows fewer estrogen side effects on cream. See estrogen on TRT. [6], [35], [50]

Red blood cells. In a network meta-analysis of 29 randomized trials, gel raised hematocrit by about 3.0 percentage points more than placebo, compared with 4.0 for enanthate or cypionate injections. That difference between gel and injections was not statistically significant, and no trial measured cream. In one clinic's records, hematocrit above 50% occurred in 12.8% of 47 men on gels and 66.7% of 57 men on injections, but the injection group was younger and started with higher hematocrit. Cream still raises it: in a UK clinic cohort on scrotal cream, average hematocrit rose from 43.9% to 46.1% over a year. See hematocrit on TRT. [10], [55], [56]

What do we actually know about testosterone cream in people?

Enough to know that cream raises testosterone, and where on the body it works best. Not enough to know how compounded creams perform over years: no outcome trial has tested a US compounded cream, and none has compared any cream with injections.

Conceptual comparison of cells in a laboratory dish, an animal study notebook, and human study records. Each answers a different research question.
Cell and animal studies explore how a medicine might work; human studies test what happens in people. Evidence on testosterone cream comes from small human studies of approved creams, product-testing studies and large trials of gel.

Which studies used testosterone cream or scrotal testosterone?

StudyWho and whatWhat it foundWhat it cannot show
Iyer 2017 (human report)11 healthy men with their own testosterone switched off; single scrotal doses of 12.5, 25 and 50 mg of AndroForte 5Fast rise; 25 mg kept normal levels for 16 hours; DHT above range; estradiol unchanged; no skin irritationRepeated dosing; men with hypogonadism [6], [3]
Wittert 2016 (controlled trial, crossover)16 men with low testosterone (14 analyzed); 100 mg cream on the torso vs 50 mg of 1% gel, 30 days eachSame blood levels; no differences in DHT, estradiol, LH or FSHLong-term outcomes; small [37]
Shirai 2023 (controlled trial, crossover)23 Japanese men; 10 mg of 2% cream vs 10 mg of 2% gel on the scrotum, 4 weeks eachGel raised testosterone more; symptoms improved on gel, not cream; no adverse eventsOther creams or doses [23]
Asih 2015 (controlled trial, crossover)44 older men with memory complaints; 50 mg scrotal cream or placebo, 24 weeks eachTestosterone and DHT up; red cells, hemoglobin and PSA up but within normal ranges; estradiol unchangedMen with hypogonadism [35], [36]
Carruthers 2015 (human report)UK clinic patients on scrotal cream, among several formsHematocrit 43.9% → 46.1% at 1 yearCause and effect; no control group; retrospective clinic records [56]
Cutter 2001 (human report)10 men on a compounded gel (not cream), 6 weeksTestosterone 136 → 442.9 ng/dL; DHT 20.5 → 199.2 ng/dL; LH suppressedUncontrolled, tiny, gel [51]
Needham 2018 (case report)1 man on scrotal compounded cream1,204.7 ng/dL within 2 hours; 1,320.6 ng/dL after 6 hoursAnything beyond one person; dose not reported in the abstract [47]
Grober 2015 (product test)Compounded products from 10 Toronto pharmacies (7 gels, 3 creams)Only 50% and 30% within 20% of prescribed strengthEffects in people [5]

The controlled cream trials used fixed doses for 4 to 24 weeks, so the longer-term safety picture comes from trials of other testosterone forms.

What did the large trials of other forms find?

  • TRAVERSE (about 5,200 men at high heart risk, daily testosterone gel for an average of 21.7 months): heart attack, stroke or heart death in 7.0% vs 7.3% on placebo (hazard ratio 0.96), which met the trial's safety margin. Atrial fibrillation, acute kidney injury, lung clots and fractures were more common, and about 61% stopped their study gel early (full results and limits). [12], [13], [57]
  • Testosterone Trials (790 men aged 65 or older, gel for 1 year): small gains in sexual function and mood; no gain in energy or walking in the physical function trial. [41]

Because cream and gel are both daily topicals, gel trials are the closest large evidence; whether compounded creams, with their variable strength and higher scrotal DHT, behave the same over years is not known.

How does testosterone cream work?

Testosterone passes through the outer layer of skin into small blood vessels over the day, so levels rise within hours of an application and drift down before the next one. The label describes the skin, not the body's clearance, as what sets the pace. [3]

Once in the blood, it acts like the body's own hormone. Some is converted to DHT, more so on scrotal skin, and some to estradiol. [3], [49]

Why it switches off your own production. The brain senses testosterone from any source. When levels are adequate, the pituitary lowers LH, the signal that tells the testicles to make testosterone, and FSH, which drives sperm production. On cream, LH fell in the 24-week trial and in the compounded gel study. [3], [35], [51]

Why it raises red blood cells. Androgens stimulate red blood cell production; that is why hematocrit is checked on every form of testosterone. [3], [10]

What are the risks and unanswered questions?

Is compounded testosterone cream safe?

Testosterone itself has well-known risks that apply to cream too; what is uncertain is the product. The AndroForte label lists transfer to other people, higher red blood cell counts, breast enlargement and fluid retention. It also lists higher blood pressure, prostate effects and reduced fertility. A compounded cream adds an unchecked dose, an unlisted base and no long-term safety studies of its own. [3], [1], [5]

Does compounded cream contain what the label says?

Not reliably. The clearest test comes from Toronto: researchers handed the same prescription (50 mg of testosterone gel or cream once daily) to 10 compounding pharmacies and tested two batches from each, a month apart.

  • Only 5 of 10 pharmacies (first batch) and 3 of 10 (second batch) made a product within 20% of the prescribed strength.
  • Two made products more than 20% too strong.
  • One made a product with essentially no testosterone.
  • Only 3 of the 10 products were creams; the other 7 were gels.
  • The approved gels used as controls were accurate.

[5]

FDA has documented the same problem in the United States: in 2019 it wrote to a compounding pharmacy that had distributed a testosterone 2 mg/gram cream measured at 126% of its labeled strength. An older FDA sampling survey from 2001 found that 10 of 29 compounded products failed at least one quality test, though none of them was a testosterone product. [58], [59]

Why can it happen? Pharmacies that compound for individual prescriptions (under section 503A of US law) are exempt from FDA approval and from federal manufacturing-quality rules (current good manufacturing practice, or CGMP), and state pharmacy boards oversee them day to day. Larger "outsourcing facilities" (section 503B) must follow CGMP and are inspected by FDA on a risk-based schedule. [60], [61], [1]

In practice this means a blood test is the only check a man has that his cream contains what he was prescribed. The AUA advises prescribers of compounded testosterone to "consider performing additional monitoring and dose adjustments". Pharmacy accreditation exists, but no source reviewed shows that it guarantees each batch. [4]

Can testosterone cream transfer to a partner or child?

Yes, and this is the most serious avoidable risk of any testosterone applied to the skin. Cream left on the skin passes to another person by direct contact. In women it can cause facial or body hair, a deeper voice and menstrual changes; in children it can cause early puberty and genital growth. The AUA makes it a strong recommendation, with its highest evidence grade, that clinicians discuss transfer with every man using a gel or cream. [3], [4]

Three published case reports describe young boys affected by a father's testosterone cream:

  • A 3.5-year-old had 6 months of genital growth and a growth spurt, with testosterone of 1,460 ng/dL. His father had used a compounded cream for about a year. The boy's level fell to 20 ng/dL within 2 months of stopping. [7]
  • A boy aged 2 years 7 months developed pubic hair and advanced bone age with testosterone of 371 ng/dL, similar to an adult man's; it returned to 10 ng/dL after his father stopped. [8]
  • A 2.67-year-old showed marked virilization (masculine changes) after presumed long-term exposure to his father's cream. [9]
Conceptual illustration of testosterone passing from treated skin to another person's skin at a point of contact, with a clothing layer blocking part of the transfer. It explains a concept, not measured amounts.
Testosterone left on the skin can pass to another person by direct contact. Washing the area and covering it with clothing blocks most transfer in gel studies. This generated illustration explains a concept; it is not clinical evidence.

No controlled study has measured transfer from cream, but gel studies show how large it can be and what prevents it. After direct skin contact with a man's gel-treated abdomen, women's testosterone rose 86–185% from baseline. A T-shirt cut transfer by about 40–48% from the abdomen and prevented it from the upper arms and shoulders. Washing the site before contact brought women's average levels back to baseline. [62], [63]

The AndroForte label's precautions:

  • Wash your hands with soap and water after applying.
  • Cover the area with clothing once the cream has dried.
  • Wash the area before any skin-to-skin contact; with scrotal use, wash the genital area with a damp warm cloth before sex.
  • Pregnant women must avoid contact with the application site.
  • Anyone touched by unwashed skin should wash that area as soon as possible.

[3]

A European safety review in 2025 also recommended a warning about transfer to pets for gels. [64] See TRT and fertility for pregnancy planning.

What side effects are reported?

The AndroForte label lists these side effects:

  • Skin and hair: increased body hair, hair loss, and oily skin (seborrhoea) or other skin reactions.
  • Breasts: breast enlargement (gynecomastia) and sensitive nipples.
  • Body and mood: fluid retention, weight gain, mood changes, nervousness and worsening sleep apnea.
  • Prostate: prostate enlargement and urinary symptoms.
  • Blood and circulation: a rise in red blood cells (polycythemia), changes in cholesterol, higher blood pressure and blood clots.
  • Sexual: frequent or prolonged erections and shrinking testicles.

Signs such as irritability, nervousness, weight gain and frequent erections can mean too high a dose. [3]

Skin reactions were less common on scrotal skin than elsewhere in the patch era: in 60 men, allergic reactions occurred in 12% with non-scrotal patches and none with scrotal patches. The AndroForte label calls skin reactions and red-cell rises "at the lowest end of the risk scale" for skin delivery. [65], [3]

Does testosterone cream affect the heart?

No heart-outcome trial has tested cream. The best evidence comes from TRAVERSE, a randomized trial of about 5,200 men aged 45 to 80 with heart disease or high heart risk, given daily 1.62% testosterone gel or a placebo gel. Among the 2,596 men who used testosterone gel and the 2,602 who used placebo gel, it found:

  • Heart attack, stroke or heart death: 182 men (7.0%) on testosterone vs 190 (7.3%) on placebo; hazard ratio 0.96, with a 95% confidence interval of 0.78 to 1.17. The top of that range stayed below the trial's safety margin of 1.5, so a large rise in risk was ruled out. [12], [13]
  • Heart rhythm: atrial fibrillation 3.5% vs 2.4%. [13]
  • Kidneys: acute kidney injury 2.3% vs 1.5%. [13]
  • Clots: venous clots 1.7% vs 1.2%, including pulmonary embolism 0.9% vs 0.5%. [13]
  • Fractures: 91 of 2,601 men (3.50%) vs 64 of 2,603 (2.46%), counting every randomized man. [57]
Paired horizontal bars showing the percent of men with each outcome in TRAVERSE, 2,596 men on testosterone gel vs 2,602 on placebo gel. Heart attack, stroke or heart death: 7.0% vs 7.3% (182 vs 190 men; hazard ratio 0.96, 95% CI 0.78–1.17; met the 1.5 safety margin); Nonfatal rhythm problems needing treatment: 5.2% vs 3.3%; Atrial fibrillation: 3.5% vs 2.4%; Clinical fracture: 3.5% vs 2.5% (91 of 2,601 vs 64 of 2,603 in the full analysis set); Acute kidney injury: 2.3% vs 1.5%; Venous clots (all): 1.7% vs 1.2%; Pulmonary embolism: 0.9% vs 0.5%. About 5,200 men aged 45–80 at high heart risk; daily gel; mean treatment 21.7 months; about 61% stopped their study gel. A trial of an approved gel, not of cream.

TRAVERSE: absolute results

Testosterone gel (2,596 men)Placebo gel (2,602 men)

Heart attack, stroke or heart death
Testosterone 7.0% vs placebo 7.3% (182 vs 190 men; hazard ratio 0.96, 95% CI 0.78–1.17; met the 1.5 safety margin)
Nonfatal rhythm problems needing treatment
Testosterone 5.2% vs placebo 3.3%
Atrial fibrillation
Testosterone 3.5% vs placebo 2.4%
Clinical fracture
Testosterone 3.5% vs placebo 2.5% (91 of 2,601 vs 64 of 2,603 in the full analysis set)
Acute kidney injury
Testosterone 2.3% vs placebo 1.5%
Venous clots (all)
Testosterone 1.7% vs placebo 1.2%
Pulmonary embolism
Testosterone 0.9% vs placebo 0.5%

About 5,200 men aged 45–80 at high heart risk; daily gel; mean treatment 21.7 months; about 61% stopped their study gel. A trial of an approved gel, not of cream.

TRAVERSE results as absolute percentages of men, testosterone gel vs placebo gel. The trial tested a gel in men at high heart risk, not a cream. Sources: Lincoff 2023 (TRAVERSE) · Kyzatrex US label (TRAVERSE results) · Snyder 2024 (fractures).

Its limits matter for cream. TRAVERSE tested only an approved gel, the average man used it for 21.7 months, about 61% stopped their study gel early, and it enrolled men at high heart risk. It did not test compounded products or the higher DHT of scrotal application. In July 2026 the Endocrine Society summarized it as showing no meaningful rise in heart attack or stroke over 1 to 4 years, but more lung clots and fractures, and said long-term safety is still not established. [12], [13], [66]

Blood pressure. All testosterone products can raise blood pressure; the AndroForte label advises caution with high blood pressure, and in February 2025 FDA added blood-pressure warnings to every US testosterone label. Several men online describe sharp rises on cream (community). [3], [67]

See TRT and heart health for the full picture.

Could testosterone cream affect the prostate?

Testosterone can enlarge the prostate and raise PSA slightly; in TRAVERSE, PSA rose about 0.15 ng/mL more than on placebo at 12 months. In TRAVERSE, which excluded men with PSA above 3.0 ng/mL, high-grade prostate cancer occurred in 5 of 2,596 men on testosterone (0.19%) vs 3 of 2,602 on placebo (0.12%), a difference that was not significant. The scrotal gel and patch studies found no prostate differences or rising PSA, but they were small. [68], [43], [50] See TRT and the prostate.

The AndroForte label contraindicates testosterone in known or suspected prostate cancer, as current US labels do, and asks for a prostate exam and PSA at least yearly, twice yearly in older or higher-risk men. [3], [69]

Checked September 2026. Rules differ by country and change often.

United States. No testosterone cream is FDA-approved; compounded cream is legal only with a valid prescription, and testosterone is a Schedule III controlled substance whatever its form. The key points:

  • Compounding law. A 503A pharmacy compounds for an individual prescription and is overseen mainly by its state board; a 503B outsourcing facility follows CGMP and is inspected by FDA. [60], [1]
  • Copies of approved drugs. FDA's 2018 guidance limits 503A pharmacies from regularly making "essentially copies" of commercially available drugs unless the prescriber records on the prescription a change that makes "a significant difference" for that patient. It is nonbinding guidance, and FDA says it does not intend to act when a pharmacy fills four or fewer such prescriptions a month. [40]
  • Testosterone as a bulk ingredient. For outsourcing facilities, testosterone sits in FDA's 503B "Category 1: bulk drug substances under evaluation" (list updated March 21, 2025), not on the final list. [70]
  • Recommendations, not rules. In July 2020 NASEM recommended that FDA's advisers review testosterone for its "Difficult to Compound List" and that compounded testosterone carry boxed warnings like approved products. FDA's difficult-to-compound list exists only as a March 2024 proposed rule, with no final action on testosterone. [20], [71]
  • Labels. In February 2025 FDA added TRAVERSE results and blood-pressure warnings to approved testosterone labels. On June 18, 2026 HHS announced that FDA is requesting further changes (removing the age-related limitation, contraindicating testosterone only in metastatic prostate cancer and revising the prostate-enlargement warning); these are requests and are not yet in any label. Compounded creams carry no FDA label at all. [67], [19]
  • Telehealth. Temporary rules let clinicians prescribe controlled medicines such as testosterone without an in-person visit through December 31, 2026; a permanent Drug Enforcement Administration (DEA) special-registration rule is still under review. [72], [73]

Canada. Testosterone is a Schedule IV controlled substance and prescription-only. No testosterone cream is among Health Canada's approved products. Compounding is regulated by the provinces and territories, and Health Canada's policy says it "must not be used as a means to bypass the federal drug review and approval system". [16], [74], [75], [33]

United Kingdom. Testosterone is a Class C controlled drug (Schedule 4 Part II), prescription-only. No testosterone cream has current UK product information; the licensed topicals are gels. A doctor can order an unlicensed "special", made or imported for an individual patient, and the BSSM describes 5% cream as licensed in Australia and available for import into the UK. [15], [76], [24], [25]

Australia. Testosterone is a Schedule 4 (prescription-only) medicine with extra controls on possession. AndroForte 5 has been approved since July 11, 2014, and is listed on the PBS, whose criteria ask for scrotal application where possible. [17], [3], [22], [42]

European Union. Rules are set nationally, and this guide did not verify the status of testosterone creams in individual member states. See TRT in Europe.

A "research use only" label on a cream does not make it legal, tested or the same as a prescribed product.

Is testosterone cream banned in sport? Does it show up on a drug test?

Yes. Testosterone is on the World Anti-Doping Agency (WADA) Prohibited List in class S1, banned in and out of competition, and the 2027 list keeps that from January 1, 2027. The AndroForte label warns athletes that it may cause a positive test. Athletes with a medical need can apply for a therapeutic use exemption, which WADA grants only when low testosterone has an organic cause (such as a testicular or pituitary disorder), not for age, obesity or earlier steroid use. [18], [77], [3], [78]

Who should be especially cautious?

  • Anyone living with children or a pregnant partner. Transfer is the cream-specific risk; the label says pregnant women must avoid contact with application sites. [3]
  • Men who want children now or soon. Testosterone suppresses sperm production, and guidelines advise against it for men trying to conceive. [4], [3]
  • Men with prostate or breast cancer. Contraindicated on the AndroForte label and current US labels. [3], [69]
  • Heart, kidney or liver disease, or high blood pressure. Fluid retention and blood-pressure rises can worsen these; the label says to monitor closely. [3]
  • A history of clots or a high hematocrit. The label advises caution with clotting disorders, and several guidelines treat a high starting hematocrit as a reason not to start. [3], [31], [34]
  • Sleep apnea, epilepsy or migraine. The label lists each as a caution. [3]
  • Nut or paraben allergy. AndroForte contains almond oil and hydroxybenzoates; compounded bases may contain other ingredients. [3]
  • Women and children. These guides are for men. Testosterone is contraindicated in pregnancy, and AndroForte is not labeled for anyone under 18; use in teenagers is specialist care only. [3]
  • Drug-tested athletes. Banned at all times. [18]
  • People taking other medicines; see the next question.

Can testosterone cream be taken with other medicines?

The AndroForte label lists these interactions:

  • Blood thinners (oral anticoagulants). Testosterone can increase their effect; the label advises more frequent blood-clotting tests (INR and prothrombin time), especially when starting and stopping. [3]
  • Insulin and diabetes medicines. Testosterone can lower blood sugar and insulin needs. [3]
  • Corticosteroids or ACTH. Together they can increase fluid retention. [3]
  • Ciclosporin, bupropion and oxyphenbutazone. Testosterone can raise ciclosporin levels and toxicity, may lower the seizure threshold with bupropion, and can raise oxyphenbutazone levels. [3]

UK labels for several testosterone products (not creams) and a 2025 European safety review add that combining testosterone with SGLT2-inhibitor diabetes medicines has been linked to higher red-cell counts. Testosterone can also lower thyroxine-binding globulin, which changes total thyroid hormone results without changing thyroid function. Bring a full list of everything you take, including supplements and anything else applied to the skin, to a pharmacist or doctor. [79], [64], [3]

What does compounded testosterone cream cost?

Checked September 2026.

There is no official price. The AUA says compounded gels and creams are "routinely less expensive than branded forms", but gives no figures. The only published prices come from a 2015 Canadian study in Toronto, where a 30-day supply cost $57.32 to $160.71. Insurance coverage for compounded products varies by plan; no official source summarizes it. Men online describe paying very different amounts for the same strength (community). [4], [5]

What should be monitored while using compounded testosterone cream?

The AndroForte label asks for testosterone levels after day 15, periodic hemoglobin, hematocrit, liver tests and cholesterol, and yearly prostate and breast checks. The numbers for acting on results come from guidelines. Use this summary to prepare questions for your prescriber; it is not a personal testing plan. [3]

Why it mattersWhat labels and guidelines sayTracking category
Testosterone level (and whether the cream contains what it should)AndroForte: after day 15, at the label's draw times (timing). Endocrine Society: 3–6 months after starting, at 12 months, then yearly. AUA: every 6–12 months, with extra checks for compounded productsBlood work; Libido; Energy Levels
HematocritUS gel labels: before starting, at 3–6 months, then yearly. Endocrine Society: stop if above 54% until it falls. AUA: intervene at 54% or higher. VA: adjust above 51%, stop above 54%. Society for Endocrinology: adjust above 50%Blood work
PSA and prostateAndroForte: exam and PSA at least yearly, twice yearly in older or higher-risk men. AUA: PSA before starting in men over 40. Endocrine Society: urology referral if PSA rises by more than 1.4 ng/mL in the first 12 months or exceeds 4.0 ng/mLBlood work; Urinary Symptoms
Blood pressureLabels: may rise; use with caution in high blood pressureBlood Pressure
Liver tests and cholesterolAndroForte: check periodicallyBlood work
Skin, breasts, mood, sleepLabels list skin reactions, acne, breast enlargement, mood changes and sleep apneaSkin Quality; Hormonal Symptoms; Mood & Wellbeing; Sleep Quality
Signs of transfer in the householdAndroForte: stop and investigate if a partner or child shows masculine changesOther (household exposure)
FertilitySemen analysis only if fertility matters; testosterone suppresses sperm productionOther (semen result)

[3], [26], [31], [4], [34], [27]

The European urology guideline monitors testosterone and hematocrit at 3, 6 and 12 months and then yearly, and the Canadian Urological Association uses its own hematocrit trigger of 55%. [32], [33] See TRT blood work and hematocrit on TRT.

Chart of on-treatment hematocrit lines by guideline on a scale from 46% to 56%, with 48–50% shaded as the range where most guidelines take care before starting. Society for Endocrinology (UK, 2022): Above 50% (0.50 L/L); VA (US, January 2026): Above 51%: adjust the dose, above 54%: stop; AUA (US, 2018, reconfirmed 2024): 54% or higher; Endocrine Society (2018): Above 54%; EAU (Europe, 2026): Above 54% (summary table: 54% or higher); BSSM (UK, 2023): Above 54%; ICSM (2024): Keep below 54%; EAA (Europe, 2020): Above 54%; CUA (Canada, 2021): 55% or higher, if it persists; Product labels (US, UK, Canada): No number: labels say “elevated”. No trial has tested which line prevents clots or heart events.

Where guidelines draw the hematocrit line on TRT

On-treatment hematocrit (%) at which each body acts.

Each bar runs from 46% (left) to 56% (right); the shaded part is 48–50%, where most guidelines take care before starting.

Society for Endocrinology (UK, 2022)
Above 50% (0.50 L/L)
VA (US, January 2026)
Above 51%: adjust the dose · above 54%: stop
AUA (US, 2018, reconfirmed 2024)
54% or higher
Endocrine Society (2018)
Above 54%
EAU (Europe, 2026)
Above 54% (summary table: 54% or higher)
BSSM (UK, 2023)
Above 54%
ICSM (2024)
Keep below 54%
EAA (Europe, 2020)
Above 54%
CUA (Canada, 2021)
55% or higher, if it persists
Product labels (US, UK, Canada)
No number: labels say “elevated”

No trial has tested which line prevents clots or heart events.

The on-treatment hematocrit levels at which each guideline acts. Product labels, including the AndroForte label, give no number. No trial has tested which line prevents clots or heart events. Sources: Society for Endocrinology 2022 · VA January 2026 · AUA 2018 · Endocrine Society 2018 · EAU 2026 · BSSM 2023 · ICSM 2024 · EAA 2020 · CUA 2021.

Write down the timing and the batch. For every testosterone result, note when and where you last applied the cream, how much, and the date on the pharmacy label. On cream, a result without its timing is hard to interpret, and a sudden change on an unchanged dose can point to a different batch. [3], [5]

What do people in public communities report?

Public forums hold every kind of cream story: men who feel better within days, men whose levels barely move, and men who stopped after acne, blood pressure spikes or worries about their families. The accounts below come from public Reddit threads from the past year and are described without identifying anyone. Most are US compounded creams; a few are Australian AndroForte users. The amounts men describe are what they reported, often well above the label's doses, and are not protocols.

What do the positive reports look like, and how long do they take?

Energy, mood and sex drive are the usual good news, often within days to weeks. One man started 200 mg a day of scrotal cream after episodes of marked fatigue. He described little change for the first few days, then better focus, energy, sleep and mood from late in the first week to about 6 weeks. He tried 300 mg briefly and went back to 200 mg. Another, on 1 mL a day for about 10 months after a starting level of 7.1 nmol/L, described better mood and motivation within days and a later level around 25 nmol/L. [80], [81]

Men who switch away also report what they miss. One man who had used scrotal cream for about 18 months moved to cypionate injections for cost and provider reasons. His energy stayed good but his sex drive nearly disappeared, and his hematocrit went from 49% on cream to about 55% on injections. [82]

Does everyone respond?

No. A man using 20% cream on his forearm for about 6 months felt only slightly better and still tested near the low end of normal; raising the dose was too expensive, so he planned injections despite disliking needles. Another man's level 14 hours after his last scrotal application came back at 83, below his pretreatment 230, after 3 months of feeling little different; his clinician suspected a lab error. A third reported a level of 300 after 4 months, compared with 446 before treatment, having skipped the application before the test. [83], [84], [85]

Some men report inconsistency on an unchanged routine: good mornings and flat mornings, or a level that jumped after 10 months on the same dose. [86], [87]

Why do the numbers vary so much?

Site and timing, mostly. One man's result was above 1,500 ng/dL on 200 mg a day of scrotal cream; his urologist halved the dose, and the same amount on his shoulders had given only 310. Another, on 150 mg a day split between the scrotum and shoulders, measured 2,242 ng/dL three hours after his morning scrotal application, and his LH and FSH were near zero. A man using 20% cream measured 293 about 24 hours after an application and 771 on an afternoon after a morning application. [44], [88], [89]

Replies in these threads repeatedly make the same point the label does: a cream result means little without the hours since application. See when blood should be drawn.

What do people say about dose units and strengths?

Confusion is common. Strengths range from 5% to 30% (300 mg/mL), and doses are described in clicks, pumps, mL, grams and mg. One man found his prescription was 10 mg/mL (1%), which he worked out as 5 mg a day. Another started a 5% AndroForte tube without understanding an instruction to use "two pumps" on an applicator marked in mL. A third asked whether 2 clicks of a 200 mg/g cream was a high dose. [90], [91], [29]

Many describe amounts above the only label's maximum. One man on a 30% (300 mg/mL) cream described applying 150 mg twice a day, later about 250 mg a day over three applications. After about 90 days his total testosterone was 1,874 and estradiol 78 (units not stated). He reported acne, oily skin and testicular shrinkage before lowering the dose. [92], [93]

What unwanted effects come up?

  • Acne. Back, chest and shoulder acne is the most common complaint. One man stopped TRT after 6 months of severe acne on 150 mg a day of scrotal cream; 6 months later new acne had mostly subsided but marks remained. [94], [95], [96]
  • Blood pressure. A man on scrotal cream reported strong energy and sex drive within 12 days, then a large rise in blood pressure that made him stop. Another, 18 months into scrotal cream, reported severe headaches and a reading of 184/110; the cause was not established. [97], [98]
  • Heart and sleep. A man who switched from AndroGel to cream reported a higher resting heart rate and poor sleep after 5 weeks, which he had not had on gel. Another reported chest pressure, anxiety and poor sleep in his first 3 days, with normal heart tests. [99], [100]
  • Nipple sensitivity and testicular shrinkage. Both come up, as they do on other forms. [101], [102]
  • Skin irritation. One man developed severe scrotal itching that worsened when his pharmacy changed the cream base, and eased when he spread the cream over a wider area. [52]
  • Hematocrit. Cream is not always the fix men hope for: one man switched from injections to lower his hematocrit and still measured 54.8% with ferritin of 9 while on cream. Others describe drops, such as 60% on injections to 49% on cream. [103], [104]

What do people report about transfer?

Worry about partners and children is a reason several men give for choosing or switching to injections. One man using cream on his arms suspected it had transferred to his partner through contact, bedding or towels after her bloodwork changed; the cause was not established. Another, on scrotal cream, noticed possible new hair growth on his partner's neck. [105], [106], [107], [92]

What do people report about cost and access?

Prices vary widely: a thread comparing 10% and 20% compounded creams in Australia found substantially different prices and fees between providers. Supply is another theme: one man switched to injections when his cream supplier became unavailable. [108], [88]

How can you judge a cream story?

Ask: What strength was it, in mg/mL, and how many mg were applied, not just clicks? Where on the body, once or twice a day? When was blood drawn relative to the last application? Was it a compounded product or an approved cream, and did the batch change? What else changed at the same time, such as hCG, an aromatase inhibitor, weight loss or training? What happened a few months later?

These selected discussions show what people experience and the questions research should answer. They are not a survey of all users, a success rate or a substitute for the studies.

How does compounded testosterone cream compare with other testosterone forms?

These are the forms most often weighed against cream. Status was checked in September 2026.

FormWhat it isRoute and labeled scheduleWhat stands outUS status
Compounded testosterone cream (this guide)Plain testosterone in a pharmacy-made baseDaily on the skin; no US label (Australian AndroForte 5: 25 mg scrotal or 100 mg torso)Strength set per prescription and not checked by FDA; scrotal use raises DHT; transfer riskNot approved; compounded [1], [3]
Testosterone gel (AndroGel and others)Approved gel with a fixed strengthFor example AndroGel 1.62%: 40.5 mg each morning on the shoulders and upper arms; not on the genitalsChecked product; boxed warning about transfer to children; gel raised hematocrit about 3 points vs placebo in trialsApproved [26], [10]
Testosterone cypionateInjected ester in oilIntramuscular (into a muscle), 50–400 mg every 2–4 weeksNo daily routine or transfer risk; bigger swings between doses; raised hematocrit about 4 points vs placebo in trialsApproved; Schedule III [69], [10]
Testosterone undecanoate injection (Aveed, Nebido)Long-acting injected esterIntramuscular (into a muscle); Aveed: 750 mg at start, at 4 weeks, then every 10 weeksFew injections; boxed warning for oil cough and allergic reactionsApproved (Aveed) [109]
Oral testosterone undecanoate (Jatenzo, Kyzatrex, Tlando)Capsules taken with foodBy mouth, twice dailyNo needles or skin transfer; blood-pressure monitoringApproved [13]
NatestoNasal gelIntranasal (into the nose): 11 mg (one spray in each nostril) three times daily, 33 mg a dayShort-acting; no skin contactApproved [110]
Testosterone pellets (Testopel)Small pellets implanted near the hipSubcutaneous (into the fatty layer under the skin), 150–450 mg every 3–6 monthsHard to adjust once insertedApproved [111]

No trial ranks these forms on long-term outcomes, and none has compared cream with injections. The practical differences are how often you dose, how much levels swing, how much hematocrit rises, whether someone else can be exposed, and whether the product's strength is checked. See testosterone gel for the closest approved alternative.

Common questions about compounded testosterone cream

Is compounded testosterone cream FDA approved?

No. No testosterone cream is FDA-approved; compounded creams are made by pharmacies for individual prescriptions, and FDA does not verify their safety, effectiveness or quality before they are used. The approved topical options in the US are gels and a solution. The only approved testosterone cream found anywhere is AndroForte 5 in Australia. [1], [2], [3] See legal status.

What is a normal starting dose of testosterone cream?

The only label, AndroForte 5, starts at 25 mg (0.5 mL of a 5% cream) once daily on the scrotum or 100 mg (2 mL) on the torso, with a maximum of 50 mg or 200 mg a day. No guideline gives a dose for compounded cream, so compounded prescriptions vary, and the right amount is found with follow-up blood tests at a consistent time after application. [3], [4] See typical protocols.

Is scrotal application safe?

It is the labeled site for AndroForte 5 and the preferred site in Australia's subsidy criteria, and it needs a much smaller dose. It raises DHT above the normal range. The label says there is no evidence this harms the prostate or heart, and a 7–10-year study of scrotal patches in 11 men found PSA stayed low. No study has measured hair loss. US gel labels forbid the genitals, and transfer during sex needs washing first. [3], [42], [50], [26] See scrotum or torso.

Is testosterone cream better than injections?

Neither has been shown better: no trial has compared cream with injections. Cream avoids needles and the peaks after each shot. In trials, gel raised hematocrit about 3.0 points and injections about 4.0, a difference that was not statistically significant; one clinic's records showed fewer high readings on gel. No trial measured cream. Injections have no transfer risk and, when approved, a checked strength. The AUA prefers commercially made products over compounded ones when possible. [3], [10], [55], [4] See how cream compares.

How do I know my compounded cream is the right strength?

You usually cannot tell without a blood test. In the Toronto study, half or fewer of the pharmacies made a product within 20% of the prescribed strength. Keep the pharmacy label, test at the same time after application each time, and ask the prescriber about retesting if a new batch behaves differently. [5], [4] See dose accuracy.

Can my partner or children be affected?

Yes. Testosterone on the skin can transfer through contact and has caused early puberty in young children. Wash your hands after applying, cover the area once dry, wash the site before skin contact, and keep pregnant women away from application sites. [3], [7] See transfer.

Does testosterone cream cause hair loss?

It can, like other forms: the AndroForte label lists hair loss. Scrotal application raises DHT, the hormone involved in male-pattern hair loss, but no study has measured whether scrotal cream causes more hair loss than other forms. [3], [6] See DHT.

How long does compounded testosterone cream last once opened?

The pharmacy sets a beyond-use date on each compounded product, and that is the limit to follow. The approved AndroForte 5 must be used within 125 days of opening and stored below 25 °C. [3], [53] See storage.

Glossary

Plain explanations of the medical, dosing and research terms used in this guide. Underlined terms in the text link here.

Adverse event
A harmful or unwanted medical event reported after someone used a treatment. A report alone does not prove the treatment caused it.
Aromatase inhibitor
A medicine, such as anastrozole, that blocks the enzyme that turns testosterone into estradiol.
Beyond-use date
The date after which a compounded medicine should not be used, set by the pharmacy that made it. It plays the role an expiry date plays on an approved product.
Bioidentical
A hormone with the same chemical structure as the one the body makes. The word describes the molecule; it says nothing about whether a product is approved, tested or accurately dosed.
CGMP (current good manufacturing practice)
Federal quality rules for how medicines are made and tested in the US. Pharmacies compounding for individual prescriptions are exempt; outsourcing facilities are not.
Compounding
When a pharmacy prepares a medicine to order from individual ingredients, instead of dispensing a factory-made product. Compounded drugs are not FDA-approved.
Controlled substance
A medicine whose prescribing and possession are restricted by law because it can be misused. Testosterone is Schedule III in the US, Schedule IV in Canada and Class C in the UK.
Controlled trial
A study that compares people who receive a treatment with a similar group who do not, often receiving a placebo instead. Randomly assigning people to each group makes the comparison fairer.
DHT (dihydrotestosterone)
A stronger androgen made from testosterone by the enzyme 5-alpha reductase, which is active in scrotal skin. It is involved in body hair, male-pattern hair loss and prostate growth.
Dose (amount each time)
The amount given on one occasion. A protocol lists both the dose and how often it is given.
Ester
A chemical tail joined to testosterone so it dissolves in oil and releases slowly after injection. Testosterone cream uses plain testosterone with no ester.
Estradiol
The main form of estrogen. In men it is made mostly from testosterone, so it can rise when testosterone rises.
FSH (follicle-stimulating hormone)
A pituitary hormone that acts on the cells supporting sperm production. Testosterone therapy lowers it.
Gynecomastia
Growth of breast tissue in men, often tender at first. It is linked to a higher estrogen-to-testosterone balance.
Hematocrit
The share of the blood made up of red blood cells. Testosterone raises it, and most guidelines act when it goes above about 54%.
Hypogonadism
Low testosterone caused by a problem in the testicles or in the brain and pituitary signals that control them, confirmed with symptoms and repeated morning blood tests.
LH (luteinizing hormone)
A pituitary hormone that tells the testicles to make testosterone. Testosterone therapy switches it off.
Outsourcing facility (503B)
A larger US compounder registered under section 503B of federal drug law. It must follow CGMP and is inspected by FDA, unlike a pharmacy compounding under section 503A.
Peak level
The highest level of a medicine in the blood after a dose. For scrotal cream it comes a few hours after application.
Pharmacokinetics
How the body absorbs, moves, breaks down and removes a substance.
Placebo
A dummy treatment with no active ingredient, used as a comparison in studies.
Polycythemia (erythrocytosis)
Too many red blood cells, shown by a high hematocrit. Testosterone therapy is a common cause.
PSA (prostate-specific antigen)
A blood test for a protein made by the prostate. It rises slightly on testosterone and is used to decide whether prostate checks are needed.
Scrotal application
Rubbing a testosterone cream or gel into the skin of the scrotum. The thin skin absorbs far more than other sites, so the labeled dose is much smaller.
Secondary exposure (transfer)
When testosterone on one person's skin passes to someone else through contact. It can cause masculine changes in women and early puberty in children.
Special (UK)
An unlicensed medicine made or imported in the UK for an individual patient after a doctor orders it.
Titration
Adjusting a dose in steps, usually based on blood tests and symptoms.
Transdermal
Absorbed through the skin, as with testosterone creams, gels and patches.
Trough level
The lowest level of a medicine in the blood, just before the next dose. For daily cream it is measured about 24 hours after the last application.
TRT (testosterone replacement therapy)
Prescribed testosterone, by cream, gel, injection or other forms, for men with low testosterone. It switches off the brain's LH and FSH signals.
WADA
The World Anti-Doping Agency, which publishes the list of substances banned in sport. Testosterone is banned at all times.
Weekly total
All the amounts given in one week, added together. For example, 25 mg a day is a 175 mg weekly total. For creams it is the applied amount, not the amount absorbed.

How this guide was researched

This guide is built from a thorough review of the sources cited throughout it: the Australian label for the only approved testosterone cream, US gel labels, clinical guidelines from the United States, Canada, the United Kingdom and Europe, published studies of testosterone cream and scrotal testosterone, product-testing studies, and regulatory documents from FDA, Health Canada, the UK and Australia. We also reviewed public online forums where men describe their own experiences with testosterone cream.

The guide cites 111 sources, including 9 product labels, 10 guidelines and position statements, and 26 original studies in people, plus 36 public community threads. Each type of source answers a different question. Labels, guidelines and trials show what was approved and measured. Product-testing studies and regulatory records show how compounded creams are made and checked. Personal accounts show what individual people experienced. Every numbered citation links to its entry below, labeled by source type.

How this guide was made

Research and drafting were AI-assisted. Every cited source was checked against the original, and the guide was reviewed and edited by Doserly before publication. It has not had an independent clinical review, and Doserly does not currently have medical reviewers. Doserly makes a medication and health-tracking app and runs Doserly Academy, both of which are promoted in this guide. Read our editorial policy for how guides are researched, updated and corrected.

This guide is for educational purposes. It summarizes what the reviewed sources report so the research is easier to understand; it is not medical advice. For a deeper dive, or to check any point for yourself, go straight to the cited sources.

Explore the sources

These are the documents cited in this guide. Labels, guidelines, studies and personal accounts answer different questions. A source being listed does not mean every statement on its page is endorsed.

Showing 111 sources

  1. 01

    Compounding and the FDA: Questions and Answers ↗

    Regulator guidance (US)

    Original page reviewed.

    Detail: Compounded drugs are not FDA-approved; FDA does not verify their safety, effectiveness or quality; they should only be used when an approved drug cannot meet a patient's needs; state boards oversee pharmacies day to day.

  2. 02

    DailyMed structured product labels: search results for testosterone ↗

    Label database (US)

    Structured listing reviewed (159 records).

    Detail: Current US testosterone labels are injections, gels, a solution, capsules, nasal gel and pellets; no testosterone cream label is listed.

  3. 03

    ANDROFORTE 5 (testosterone) 5% w/v cream: Australian product information ↗

    Product information (Australia)

    Full product information reviewed.

    Detail: 25 mg (0.5 mL) daily to the scrotum or 100 mg (2 mL) to the torso, at most 50 mg or 200 mg; draws at 3 and 24 hours (scrotal) or before the morning dose (torso) after day 15; transfer precautions; store below 25 °C and use within 125 days of opening.

  4. 04

    Evaluation and Management of Testosterone Deficiency: AUA Guideline ↗

    Clinical practice guideline

    Original full text reviewed.

    Detail: Prescribe commercially manufactured testosterone rather than compounded when possible; consider extra monitoring with compounded products; discuss transfer with gel and cream users (strong recommendation); target 450–600 ng/dL.

  5. 05

    Accuracy of testosterone concentrations in compounded testosterone products ↗

    Product-testing study

    Original abstract reviewed.

    Result detail: 10 Toronto pharmacies, 50 mg daily prescription (7 gels and 3 creams made): only 50% and 30% of pharmacies within ±20% of the prescribed dose; one product had essentially no testosterone; 30-day cost $57.32 to $160.71 (Canadian study).

  6. 06

    Pharmacokinetics of testosterone cream applied to scrotal skin ↗

    Human study (pharmacokinetics)

    Original abstract reviewed; full results as reported in the AndroForte 5 product information.

    Result detail: 11 men with their own testosterone suppressed; single scrotal doses of 12.5, 25 and 50 mg; peak at 1.9–2.8 hours in the abstract (label mean 3.3–5.3 hours); 25 mg kept normal levels for 16 hours; DHT peaked above range; estradiol unchanged.

  7. 07

    Sexual precocity in the setting of parental use of a compounded testosterone cream: case report and review of the literature ↗

    Human report (case)

    Original abstract reviewed.

    Result detail: 3.5-year-old boy, testosterone 1,460 ng/dL; 20 ng/dL within 2 months of his father stopping.

  8. 08

    Sexual precocity in a 2-year-old boy caused by indirect exposure to testosterone cream ↗

    Human report (case)

    Original abstract reviewed.

    Result detail: Testosterone 371 ng/dL with advanced bone age; 10 ng/dL after the father stopped.

  9. 09

    Precocious puberty secondary to topical testosterone exposure ↗

    Human report (case)

    Original abstract reviewed.

    Result detail: Marked virilization in a 2.67-year-old after presumed long-term exposure to his father's testosterone cream.

  10. 10

    The Effect of Route of Testosterone on Changes in Hematocrit: A Systematic Review and Bayesian Network Meta-Analysis of Randomized Trials ↗

    Meta-analysis of trials

    Original abstract reviewed.

    Result detail: 29 trials; hematocrit rise vs placebo about 3.0 points for gel and 4.0 for enanthate or cypionate injections; only injections vs patch differed significantly.

  11. 11

    Oral enclomiphene citrate raises testosterone and preserves sperm counts in obese hypogonadal men, unlike topical testosterone: restoration instead of replacement ↗

    Human trial (randomized)

    Original abstract reviewed.

    Result detail: In two phase 3 trials, AndroGel 1.62% markedly reduced sperm production over 16 weeks, while enclomiphene kept it normal.

  12. 12

    Cardiovascular Safety of Testosterone-Replacement Therapy (TRAVERSE) ↗

    Human trial (randomized)

    Original abstract reviewed.

    Result detail: 5,204 men on daily gel or placebo; heart attack, stroke or heart death 7.0% vs 7.3% (hazard ratio 0.96); mean treatment 21.7 months.

  13. 13

    KYZATREX (testosterone undecanoate) capsules ↗

    Product label (US)

    Full label reviewed.

    Detail: Twice-daily capsules with food; carries the TRAVERSE results (atrial fibrillation 3.5% vs 2.4%, acute kidney injury 2.3% vs 1.5%, pulmonary embolism 0.9% vs 0.5%).

  14. 14

    21 CFR 1308.13 Schedule III (anabolic steroids) ↗

    Regulation (US)

    Original page reviewed.

    Detail: Anabolic steroids, including testosterone, are Schedule III.

  15. 15

    Misuse of Drugs Act 1971, Schedule 2 Part III (Class C drugs) ↗

    Legislation (UK)

    Original page reviewed.

    Detail: Testosterone is a Class C controlled drug.

  16. 16

    Controlled Drugs and Substances Act (S.C. 1996, c. 19), Schedule IV ↗

    Legislation (Canada)

    Original page reviewed.

    Detail: Anabolic steroids, including testosterone, are Schedule IV.

  17. 17

    Therapeutic Goods (Poisons Standard, June 2026) Instrument 2026 ↗

    Legislation (Australia)

    Original page reviewed.

    Detail: Testosterone is Schedule 4 (prescription only), with Appendix D controls on possession.

  18. 18

    World Anti-Doping Code International Standard: Prohibited List 2026 ↗

    Anti-doping rule

    Original document reviewed.

    Detail: Testosterone is an S1 anabolic agent, prohibited at all times.

  19. 19

    HHS Announces Requested Updates to Testosterone Therapy Product Labels ↗

    Regulator notice (US)

    Original page reviewed.

    Detail: FDA is requesting removal of the age-related limitation, a contraindication only in metastatic prostate cancer and a revised prostate-enlargement warning; requested, not yet in labels (checked Sep 2026).

  20. 20

    The Clinical Utility of Compounded Bioidentical Hormone Therapy: A Review of Safety, Effectiveness, and Use (Summary) ↗

    Expert committee report

    Original summary chapter reviewed.

    Detail: Insufficient evidence for compounded hormones in male hypogonadism; limit use to documented allergy or a needed dosage form; boxed warnings for compounded testosterone; review testosterone for the difficult-to-compound list.

  21. 21

    Compounded Bioidentical Hormones in Endocrinology Practice: An Endocrine Society Scientific Statement ↗

    Scientific statement

    Original abstract reviewed.

    Detail: "No rationale for routine prescribing of unregulated, untested, and potentially harmful custom compounded bioidentical hormone therapies."

  22. 22

    Testosterone medicines with current Australian product information (TGA) ↗

    Product information listings (Australia)

    Current product information documents reviewed.

    Detail: Current documents include AndroForte 5 cream alongside Testogel and Testavan gels and several injections.

  23. 23

    Novel testosterone gel improves serum testosterone concentrations and aging males' symptoms in patients with late-onset hypogonadism: an active control equivalence, randomized, double-blind, crossover study ↗

    Human trial (randomized crossover)

    Original full text reviewed.

    Result detail: 23 men; 10 mg on the scrotum daily for 4 weeks; total testosterone 9.86 ng/mL on 2% gel vs 7.30 on the imported 2% cream; symptoms improved on gel only.

  24. 24

    Supply unlicensed medicinal products (specials): MHRA Guidance Note 14 ↗

    Regulator guidance (UK)

    Original page reviewed.

    Detail: Specials are products specially manufactured or imported for an individual patient after being ordered by a doctor or other prescriber.

  25. 25

    The British Society for Sexual Medicine Guidelines on Male Adult Testosterone Deficiency, with Statements for Practice ↗

    Clinical practice guideline

    Original full text reviewed.

    Detail: Lists 5% testosterone cream (small volume to the scrotum) as licensed in Australia and for import into the UK; gels sampled 2–4 hours after application; target 15–30 nmol/L.

  26. 26

    ANDROGEL (testosterone gel) 1.62% ↗

    Product label (US)

    Full label reviewed.

    Detail: Starts at 40.5 mg each morning on the shoulders and upper arms, not the genitals; boxed warning on secondary exposure of children; hematocrit before, at 3–6 months, then yearly; levels return to about baseline 48–72 hours after the last dose.

  27. 27

    Society for Endocrinology guidelines for testosterone replacement therapy in male hypogonadism ↗

    Clinical practice guideline

    Original full text reviewed.

    Detail: Gels sampled 2–6 hours after application aiming for mid-normal; adjust if hematocrit is above 50%; treatment is lifelong once the diagnosis is confirmed.

  28. 28

    Testosterone Therapy for Late-Onset Hypogonadism: A Clinical, Biological, and Analytical Approach Using Compounded Testosterone 0.5–20% Topical Gels ↗

    Human report and laboratory study

    Original full text reviewed.

    Result detail: One patient used two pumps of about 0.5 mL each of a 5% gel (about 50 mg) daily; authors are affiliated with the maker of the gel base.

  29. 29

    TRT Cream - Is Two Clicks (0.5ml) Testosterone 200mg/g - 200mg/g Cream Daily a high dosage? ↗

    Community account

    Public thread reviewed: opening post and 11 comments.

    Detail: The poster started testosterone cream five weeks earlier at two clicks, described as 0.5 mL of a 200 mg/g cream daily.

  30. 30

    ANDROGEL (testosterone gel) 1% ↗

    Product label (US)

    Full label reviewed.

    Detail: About 10% of the applied dose is absorbed; not for the genitals; wait 5 hours before showering; levels back to pretreatment by the fifth day after stopping; testosterone half-life in blood 10 to 100 minutes.

  31. 31

    Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline ↗

    Clinical practice guideline

    Original full text reviewed.

    Detail: Gels measured 2–8 hours after application after at least 1 week; testosterone and hematocrit at 3–6 months, 12 months and yearly; stop if hematocrit is above 54%.

  32. 32

    EAU Guidelines on Sexual and Reproductive Health, Chapter 3: Male Hypogonadism ↗

    Clinical practice guideline

    Original full text reviewed.

    Detail: Monitor testosterone and hematocrit at 3, 6 and 12 months, then yearly; act on hematocrit above 54%; no cream dose given.

  33. 33

    Canadian Urological Association guideline on testosterone deficiency in men: Evidence-based Q&A ↗

    Clinical practice guideline

    Original full text reviewed.

    Detail: Warns of significant variability of testosterone concentrations in compounded products; changes expected after 3 months or longer; hematocrit trigger 55%.

  34. 34

    Evaluation for and Management of Males with Low Testosterone: Recommendations for Use ↗

    Health-system clinical recommendations

    Original full text reviewed.

    Detail: Adjust above hematocrit 51%, stop above 54%; no cream dose given.

  35. 35

    Testosterone replacement therapy in older male subjective memory complainers: double-blind randomized crossover placebo-controlled clinical trial of physiological assessment and safety ↗

    Human trial (randomized, placebo-controlled crossover)

    Original abstract reviewed.

    Result detail: 44 men aged about 61; 50 mg daily for 24 weeks; testosterone and DHT rose, LH fell; red cells, hemoglobin and PSA rose within normal ranges; estradiol unchanged.

  36. 36

    The Effects of Testosterone Supplementation on Cognitive Functioning in Older Men ↗

    Human trial (same trial, companion report)

    Original full text reviewed.

    Result detail: Confirms the regimen: 50 mg of AndroForte 5% applied daily to the scrotum for 24 weeks.

  37. 37

    An open-label, phase 2, single centre, randomized, crossover design bioequivalence study of AndroForte 5 testosterone cream and Testogel 1% testosterone gel in hypogonadal men: study LP101 ↗

    Human trial (randomized crossover)

    Original abstract reviewed.

    Result detail: 16 men enrolled, 14 analyzed; 100 mg cream on the torso and 50 mg of 1% gel gave equivalent exposure at day 30 (AUC ratio 0.99).

  38. 38

    Test Cream Feedback ↗

    Community account

    Public thread reviewed: opening post and 42 comments.

    Detail: The poster had been prescribed injections but could not proceed because of severe needle fear.

  39. 39

    TRT - Anyone doing well on creams? Injection reactions ↗

    Community account

    Public thread reviewed: opening post and 20 comments.

    Detail: The poster stopped testosterone injections after severe reactions during the first two weeks and asked whether compounded cream could provide a stable response.

  40. 40

    Compounded Drug Products That Are Essentially Copies of a Commercially Available Drug Product Under Section 503A: Guidance for Industry ↗

    Regulator guidance (US, nonbinding)

    Original full text reviewed.

    Detail: A change that makes a significant difference for an identified patient, recorded on the prescription, takes a product outside "essentially a copy"; FDA does not intend to act at four or fewer such prescriptions a month.

  41. 41

    Effects of Testosterone Treatment in Older Men ↗

    Human trial (randomized)

    Original full text reviewed.

    Result detail: 790 men aged 65 or older; a year of gel improved sexual function a little, not energy or walking in the physical function trial.

  42. 42

    PBS item pages and restrictions for testosterone (Schedule, September 2026) ↗

    Subsidy listing (Australia)

    Original pages reviewed.

    Detail: AndroForte 5 restrictions add that the treatment must be applied to the scrotum, where possible.

  43. 43

    Testosterone substitution with a new transdermal, hydroalcoholic gel applied to scrotal or non-scrotal skin: a multicentre trial ↗

    Human trial (randomized)

    Original abstract reviewed.

    Result detail: 162 men, 24 weeks; gel washed off 10 minutes after application; 25 mg scrotal gel equivalent to patches, 125 mg non-scrotal gel superior; no differences in prostate volume, PSA or prostate symptoms.

  44. 44

    49 3 months TRT cream ↗

    Community account

    Public thread reviewed: opening post and 38 comments.

    Detail: The poster used testosterone cream for three months, initially applying 100 mg morning and night to the scrotum.

  45. 45

    Day 27 300mg/ml cream split 2 150mg doses; 17lb weight gain. 1 month bloodwork? T ↗

    Community account

    Public thread reviewed: opening post and 5 comments.

    Detail: The poster started a compounded 300 mg/mL testosterone cream at 150 mg twice daily.

  46. 46

    TRT Cream issues ↗

    Community account

    Public thread reviewed: opening post and 28 comments.

    Detail: The poster used compounded testosterone cream on both shoulders and reduced the daily dose after blood pressure reached 150/100.

  47. 47

    Case Study: Absorption of Testosterone Cream via Scrotal Delivery ↗

    Human report (single case)

    Original abstract reviewed.

    Result detail: 1,204.7 ng/dL within 2 hours and 1,320.6 ng/dL beyond 6 hours after scrotal compounded cream.

  48. 48

    Rate, extent, and modifiers of spermatogenic recovery after hormonal male contraception: an integrated analysis ↗

    Human study (pooled analysis)

    Original abstract reviewed.

    Result detail: 1,549 healthy men; sperm back to 20 million/mL in 67% by 6 months, 90% by 12 and 100% by 24 months.

  49. 49

    Transdermal testosterone therapy in the treatment of male hypogonadism ↗

    Human study

    Original abstract reviewed.

    Result detail: 5 men on scrotal patches; DHT-to-testosterone ratio rose from 0.2 to 0.6, attributed to 5-alpha reductase in scrotal skin.

  50. 50

    Long-term substitution therapy of hypogonadal men with transscrotal testosterone over 7–10 years ↗

    Human study

    Original abstract reviewed.

    Result detail: 11 men on scrotal patches; DHT 1.3 to 3.9 nmol/L and estradiol 52.3 to 71.3 pmol/L, stable; hemoglobin normal; PSA constantly low.

  51. 51

    Compounded percutaneous testosterone gel: use and effects in hypogonadal men ↗

    Human study (uncontrolled)

    Original abstract reviewed.

    Result detail: 10 men, 6 weeks: total testosterone 136 to 442.9 ng/dL; DHT 20.5 to 199.2 ng/dL; LH 5.66 to 1.10 mIU/mL.

  52. 52

    Testosterone cream ↗

    Community account

    Public thread reviewed: opening post and 8 comments.

    Detail: The poster developed severe scrotal itching with testosterone cream and said changing from one cream base to another made it worse.

  53. 53

    Stability of Fagron's Phytobase Cream Compounded with Various Hormones ↗

    Laboratory stability study

    Original abstract reviewed.

    Result detail: Testosterone 0.1% and 20% in one cream base and pump container supported a 180-day beyond-use date.

  54. 54

    Effects of skin washing on systemic absorption of testosterone in hypogonadal males after administration of 1.62% testosterone gel ↗

    Human study (pharmacokinetics)

    Original abstract reviewed.

    Result detail: Washing at 2 or 6 hours lowered exposure 10–14%; washing at 10 hours had no effect.

  55. 55

    Comparison of the Effects of Testosterone Gels, Injections, and Pellets on Serum Hormones, Erythrocytosis, Lipids, and Prostate-Specific Antigen ↗

    Human study (clinic records)

    Original abstract reviewed.

    Result detail: Hematocrit above 50% in 12.8% of 47 men on gels, 35.1% of 74 on pellets and 66.7% of 57 on injections; the injection group was younger with higher starting hematocrit.

  56. 56

    Evolution of testosterone treatment over 25 years: symptom responses, endocrine profiles and cardiovascular changes ↗

    Human study (retrospective clinic cohort)

    Original full text reviewed.

    Result detail: In the scrotal cream group, hematocrit rose from 0.439 to 0.461 and hemoglobin from 15.0 to 15.7 g/dL after 1 year.

  57. 57

    Testosterone Treatment and Fractures in Men with Hypogonadism ↗

    Human trial (randomized; TRAVERSE substudy)

    Original abstract reviewed.

    Result detail: Clinical fractures 91 of 2,601 (3.50%) vs 64 of 2,603 (2.46%).

  58. 58

    FDA untitled letter to a compounding pharmacy (CMS 584458) ↗

    Regulator letter (US)

    Original full text reviewed.

    Detail: The pharmacy distributed a testosterone 2 mg/gram cream measured at 126% of the labeled amount.

  59. 59

    Report: Limited FDA Survey of Compounded Drug Products ↗

    Regulator report (US)

    Original page reviewed.

    Detail: 10 of 29 sampled compounded products failed one or more quality tests; no testosterone product was sampled.

  60. 60

    Human Drug Compounding Laws ↗

    Regulator guidance (US)

    Original page reviewed.

    Detail: 503A compounding is exempt from approval, CGMP and adequate-directions labeling; 503B outsourcing facilities must follow CGMP and are inspected on a risk-based schedule.

  61. 61

    FD&C Act Provisions that Apply to Human Drug Compounding ↗

    Regulator guidance (US)

    Original page reviewed.

    Detail: Chart of the federal requirements that do and do not apply to 503A pharmacies and 503B outsourcing facilities.

  62. 62

    Serum testosterone levels in non-dosed females after secondary exposure to 1.62% testosterone gel: effects of clothing barrier on testosterone absorption ↗

    Human study (transfer)

    Original abstract reviewed.

    Result detail: Women's testosterone rose 86–185% after direct contact with a gel-treated abdomen; a T-shirt cut transfer by about 40–48% from the abdomen and prevented it from the arms and shoulders.

  63. 63

    Effect of application site, clothing barrier, and application site washing on testosterone transfer with a 1.62% testosterone gel ↗

    Human study (transfer)

    Original abstract reviewed.

    Result detail: 24 couples; washing the site before contact brought women's average levels back to baseline.

  64. 64

    Minutes of the PRAC meeting, 1–4 September 2025 (testosterone periodic safety reviews) ↗

    Regulator minutes (EU)

    Original document reviewed.

    Detail: Benefit-risk unchanged; recommended an SGLT2-inhibitor interaction warning for all forms and a pets transfer warning for gels.

  65. 65

    Allergy and topical irritation associated with transdermal testosterone administration: a comparison of scrotal and nonscrotal transdermal systems ↗

    Human trial (randomized crossover)

    Original abstract reviewed.

    Result detail: 60 men; contact allergy in 12% with non-scrotal patches and no confirmed cases with scrotal patches.

  66. 66

    Statement on Testosterone Replacement Therapy ↗

    Position statement

    Original page reviewed.

    Detail: TRAVERSE showed no meaningful rise in heart attack or stroke over 1–4 years, but more pulmonary embolism and fractures; long-term safety not established.

  67. 67

    FDA issues class-wide labeling changes for testosterone products ↗

    Regulator notice (US)

    Original page reviewed.

    Detail: Adds TRAVERSE results and blood-pressure warnings to testosterone labels.

  68. 68

    Prostate Safety Events During Testosterone Replacement Therapy in Men With Hypogonadism: A Randomized Clinical Trial ↗

    Human trial (randomized; TRAVERSE substudy)

    Original full text reviewed.

    Result detail: High-grade prostate cancer 5 of 2,596 (0.19%) vs 3 of 2,602 (0.12%); PSA about 0.15 ng/mL higher than placebo at 12 months.

  69. 69

    DEPO-Testosterone (testosterone cypionate) injection, USP CIII ↗

    Product label (US)

    Full label reviewed.

    Detail: 50–400 mg every 2–4 weeks intramuscularly; contraindicated in known or suspected prostate or breast cancer.

  70. 70

    Bulk Drug Substances Nominated for Use in Compounding Under Section 503B (categories) ↗

    Regulator list (US)

    Original document reviewed.

    Detail: Testosterone and its esters are in Category 1 (under evaluation), not on the final 503B bulks list.

  71. 71

    Human Drug Compounding Policies and Rules (index) ↗

    Regulator index (US)

    Original page reviewed.

    Detail: The demonstrably-difficult-to-compound list exists only as a March 2024 proposed rule; no final action on testosterone.

  72. 72

    Fourth Temporary Extension of COVID-19 Telemedicine Flexibilities for Prescription of Controlled Medications ↗

    Regulation (US)

    Original page reviewed.

    Detail: Flexibilities run from January 1 to December 31, 2026.

  73. 73

    OIRA review record: Special Registrations for Telemedicine (RIN 1117-AB40), final rule stage ↗

    Regulatory record (US)

    Original page reviewed.

    Detail: The DEA special-registration final rule is under review, not published (checked September 2026).

  74. 74

    Drug Product Database: testosterone products and status history ↗

    Regulator database (Canada)

    Structured database records reviewed.

    Detail: Marketed topicals are gels (AndroGel 1%, Testim 1%, Taro gel) and Natesto; no testosterone cream; all products under CDSA Schedule IV.

  75. 75

    Policy on Manufacturing and Compounding Drug Products in Canada (POL-0051) ↗

    Regulator policy (Canada)

    Original page reviewed.

    Detail: Compounding is regulated by the provinces and territories and must not be used to bypass the federal drug review and approval system.

  76. 76

    Testosterone medicines with current UK product information (electronic medicines compendium) ↗

    Product information listings (UK)

    Current listings reviewed.

    Detail: Current UK testosterone topicals are gels (Testogel, Irisel, Tostran, Testavan); no testosterone cream.

  77. 77

    World Anti-Doping Code International Standard: Prohibited List 2027 ↗

    Anti-doping rule

    Original document reviewed.

    Detail: Keeps testosterone prohibited at all times.

  78. 78

    TUE Physician Guidelines: Male Hypogonadism, Version 9 ↗

    Anti-doping guidance

    Original document reviewed.

    Detail: Exemptions only for organic hypogonadism, not functional low testosterone from aging, obesity or earlier steroid use.

  79. 79

    Nebido 1000 mg/4 ml solution for injection: summary of product characteristics ↗

    Product information (UK)

    Full product information reviewed.

    Detail: Warns that combining testosterone with SGLT2 inhibitors has been associated with increased erythrocytosis.

  80. 80

    200mg daily testosterone cream : Weekly Diary ↗

    Community account

    Public thread reviewed: opening post and 5 comments.

    Detail: The poster began daily scrotal testosterone cream after episodes of marked fatigue and a low baseline testosterone result.

  81. 81

    stopped trt cream ↗

    Community account

    Public thread reviewed: opening post and 5 comments.

    Detail: The poster used testosterone cream at 1 mL daily for about ten months after a total testosterone reading of 7.1 nmol.

  82. 82

    Went injections from cream - libido disappeared ↗

    Community account

    Public thread reviewed: opening post and 15 comments.

    Detail: The poster used scrotal cream for about a year and a half and said it promptly relieved fatigue, brain fog, and low libido.

  83. 83

    I’m Switching from Cream to Injections ↗

    Community account

    Public thread reviewed: opening post and 26 comments.

    Detail: The poster used 20% testosterone cream at two clicks daily for about six months but reported only slight improvement and testosterone still near the low end of the normal range.

  84. 84

    First Bloods- 3 months on cream two clicks twice a day and 14 hours applied before getting bloods- 83 seem low? Doc appt. about it next week but wondering if this is normal? Honestly I dont feel much different then I started(T230). ↗

    Community account

    Public thread reviewed: opening post and 17 comments.

    Detail: The poster used cream on a shaved scrotum for three months and felt little different from before treatment.

  85. 85

    Test cream ↗

    Community account

    Public thread reviewed: opening post and 17 comments.

    Detail: The poster had used testosterone cream once daily for 4 months and reported total testosterone of 300, compared with 446 before TRT.

  86. 86

    Anyone switch from cream to injections because absorption felt inconsistent? ↗

    Community account

    Public thread reviewed: opening post and 1 comments.

    Detail: The poster had used compounded testosterone cream for a few months with the same application routine but felt good on some mornings and unchanged on others.

  87. 87

    Sudden spike in Test levels after a year on Test cream ↗

    Community account

    Public thread reviewed: opening post.

    Detail: The poster used testosterone cream on the scrotum once daily for 10 months and initially noticed better mood, libido, and energy.

  88. 88

    Hyper-Responder to Scrotal Cream, 2242 ng/dL After 4 Weeks, Advice Needed ↗

    Community account

    Public thread reviewed: opening post and 7 comments.

    Detail: The poster began compounded testosterone cream with a larger morning scrotal dose and a smaller late-afternoon shoulder dose.

  89. 89

    Cream question ↗

    Community account

    Public thread reviewed: opening post and 2 comments.

    Detail: The poster switched from years of injections to 20% cream because hematocrit had been rising while ferritin was low.

  90. 90

    Dosing for Testosterone Cream Versus Injections ↗

    Community account

    Public thread reviewed: opening post and 10 comments.

    Detail: After four years on testosterone cypionate injections, the poster began transitioning to cream applied to the shoulder.

  91. 91

    Androforte 5 cream ↗

    Community account

    Public thread reviewed: opening post and 24 comments.

    Detail: The poster had just changed from testosterone enanthate injections to a 5% testosterone cream but did not understand an instruction to use two pumps because the supplied dispenser was marked in milliliters.

  92. 92

    Day 56 300mg/ml test cream update ↗

    Community account

    Public thread reviewed: opening post and 40 comments.

    Detail: The poster started a 30% compounded testosterone cream after low testosterone results, applying it to the scrotum and eventually splitting about 250 mg across three daily applications.

  93. 93

    90day (30%) 300mg/ml (150/150 split) test cream results. Total test 1874, estradiol 78; hemoglobin 13.8; hemocrit 44; monocytes 10.1 ↗

    Community account

    Public thread reviewed: opening post.

    Detail: The poster used 300 mg/mL testosterone cream, applying 150 mg twice daily for about 90 days.

  94. 94

    Severe acne from TRT cream (scrotal) — considering switching to injections, looking for advice ↗

    Community account

    Public thread reviewed: opening post and 17 comments.

    Detail: The poster used 150 mg daily of scrotal testosterone cream for about six months and felt mentally better overall.

  95. 95

    Testosterone 20% compound cream results ↗

    Community account

    Public thread reviewed: opening post and 15 comments.

    Detail: The poster used 20% compounded testosterone cream, one 0.5 mL pump to the scrotum in the morning and another in the evening.

  96. 96

    Been on TRT 120 mg of Test E injections for 4weeks changing over from cream, are these levels acceptable/safe long term? ↗

    Community account

    Public thread reviewed: opening post and 27 comments.

    Detail: The poster used 10% testosterone cream for four months before switching to testosterone enanthate injections.

  97. 97

    200 MG Cream and almost no results ↗

    Community account

    Public thread reviewed: opening post and 16 comments.

    Detail: The poster began compounded cream after a total testosterone reading of 175.

  98. 98

    Trt cream (2 pumps daily to balls) for about 18 months. This week I’ve had crippling headaches all day/night that’s stopped me driving and working. ↗

    Community account

    Public thread reviewed: opening post and 5 comments.

    Detail: The poster had applied testosterone cream to the scrotum for about 18 months.

  99. 99

    Has anyone else noticed much stronger side effects on the cream vs the gel? After switching from androgel to cream, suddenly my heart rate is 15% higher and I can't sleep at night. On Androgel I had none of these issues. Low heart rate and great sleep. ↗

    Community account

    Public thread reviewed: opening post and 16 comments.

    Detail: The poster felt fairly well and slept well on testosterone gel, then switched to cream hoping for better absorption.

  100. 100

    Started Compounded Cream - Experiencing Sides ↗

    Community account

    Public thread reviewed: opening post and 16 comments.

    Detail: The poster switched from testosterone injections to compounded cream after reactions to multiple injection carrier oils.

  101. 101

    2 Months, my experience starting on TRT 20% compound cream ↗

    Community account

    Public thread reviewed: opening post and 17 comments.

    Detail: The poster used 20% compounded cream on the scrotum for about two months.

  102. 102

    Testosterone replacement therapy cream ↗

    Community account

    Public thread reviewed: opening post and 4 comments.

    Detail: The poster had used TRT cream for five months and reported lower total and free testosterone than before treatment.

  103. 103

    Cream was supposed to help with Hematocrit levels and hopefully ferritin... ↗

    Community account

    Public thread reviewed: opening post and 18 comments.

    Detail: After years of injections complicated by high hematocrit and repeated blood donations, the poster switched to testosterone cream hoping his blood counts and ferritin would improve.

  104. 104

    Cream - A Superpower Solution ↗

    Community account

    Public thread reviewed: opening post and 24 comments.

    Detail: The poster switched from testosterone injections to scrotal cream after struggling with elevated hematocrit.

  105. 105

    Pivoting from Compounded Cream to Injections with Urology ↗

    Community account

    Public thread reviewed: opening post and 4 comments.

    Detail: The poster had repeated low testosterone readings and was prescribed one 50 mg click of compounded cream daily.

  106. 106

    Cream vs EOD injections for a newbie ↗

    Community account

    Public thread reviewed: opening post and 5 comments.

    Detail: The poster had recently started 7.5% compounded testosterone cream at 75 mg daily.

  107. 107

    I’m switching from cream to injection. Has anyone found it to be beneficial? ↗

    Community account

    Public thread reviewed: opening post and 36 comments.

    Detail: The poster was preparing to switch from cream to twice-weekly injections because he found the cream inconsistent.

  108. 108

    Compounded cream pricing 10%/15/20% ↗

    Community account

    Public thread reviewed: opening post and 15 comments.

    Detail: The poster asked what compounded testosterone cream costs at different concentrations and supply sizes while researching TRT providers.

  109. 109

    AVEED (testosterone undecanoate) injection ↗

    Product label (US)

    Full label reviewed.

    Detail: 750 mg at start, at 4 weeks, then every 10 weeks; boxed warning for oil microembolism and anaphylaxis.

  110. 110

    NATESTO (testosterone) nasal gel ↗

    Product label (US)

    Full label reviewed.

    Detail: 11 mg (one spray in each nostril) three times daily, a total of 33 mg a day.

  111. 111

    TESTOPEL (testosterone pellets) for subcutaneous implantation ↗

    Product label (US)

    Full label reviewed.

    Detail: 150–450 mg (two to six 75 mg pellets) every 3 to 6 months.

Updates and corrections

Updated September 28, 2026. This version replaces the earlier compounded testosterone cream guide with a rewrite anchored to the only approved testosterone cream label (AndroForte 5, Australia), current guidelines and FDA's compounding records. It adds a protocol table with each schedule's source, the evidence on how accurately compounded creams are dosed, published cases of transfer to children, blood-test timing for cream, storage rules, the full TRAVERSE results, what happens when cream stops, a comparison with other forms and a dated legal-status summary. It corrects the earlier page on several points: the scrotal pharmacokinetics study is Iyer 2017 (Andrology 5(4):725–731), the compounded gel study's author is Cutter, and the scrotal case report is in volume 22, issue 6; TRAVERSE's safety margin was 1.5 and it studied about 5,200 men; the earlier clinic dose of 50–100 mg on the scrotum, the 20–40% scrotal absorption figure, the 12-hour trough rule, the 38-trial review and the 79% price saving had no verifiable source and were removed; compounding pharmacy names were removed. The date describes this revision, not a fresh check of every source.

Found an error or a relevant study we missed? Report a correction with the guide title, the specific passage and a supporting source if available. Please leave out personal health records. See our editorial policy for how we handle attribution, evidence limits and corrections.